Drug–drug interaction between levetiracetam and non-vitamin K antagonist anticoagulants

por Mathy, François-Xavier, Dohin, Elisabeth, Bonfitto, François, Pelgrims, Barbara
Publicado 2019

Development of lacosamide for the treatment of partial-onset seizures

por Doty, Pamela, Hebert, David, Mathy, Francois-Xavier, Byrnes, William, Zackheim, James, Simontacchi, Kelly
Publicado 2013

An Update on Pharmacological, Pharmacokinetic Properties and Drug–Drug Interactions of Rotigotine Transdermal System in Parkinson’s Disease and Restless Legs Syndrome

por Elshoff, Jan-Peer, Cawello, Willi, Andreas, Jens-Otto, Mathy, Francois-Xavier, Braun, Marina
Publicado 2015

In Vivo Methods for the Assessment of Topical Drug Bioavailability

por Herkenne, Christophe, Alberti, Ingo, Naik, Aarti, Kalia, Yogeshvar N., Mathy, François-Xavier, Préat, Véronique, Guy, Richard H.
Publicado 2007

Testing the nonclinical Comprehensive In Vitro Proarrhythmia Assay (CiPA) paradigm with an established anti‐seizure medication: Levetiracetam case study

por Delaunois, Annie, Mathy, François‐Xavier, Cornet, Miranda, Gryshkova, Vitalina, Korlowski, Chloé, Bonfitto, François, Koch, Juliane, Schlit, Anne‐Françoise, Hebeisen, Simon, Passini, Elisa, Rodriguez, Blanca, Valentin, Jean‐Pierre
Publicado 2023

Phase 1/1b Studies of UCB0599, an Oral Inhibitor of α‐Synuclein Misfolding, Including a Randomized Study in Parkinson's Disease

por Smit, Johan Willem, Basile, Peter, Prato, Maria Key, Detalle, Laurent, Mathy, François‐Xavier, Schmidt, Astrid, Lalla, Marianna, Germani, Massimiliano, Domange, Coralie, Biere, Anja‐Leona, Bani, Massimo, Carson, Stan, Genius, Just
Publicado 2022